Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Vatiquinone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PTC Therapeutics reports second trial flop for late-stage program
    PTC Therapeutics reports second trial flop for late-stage program

    01 Jul 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/ptc-therapeutics-reports-second-trial-flop-for-vatiquinone-in-mitochondrial-disease-seizures/

    Katherine Lewin ENDPTS
    01 Jul 2023
    Share Share
    PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone
    PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone

    29 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-results-from-mit-e-clinical-trial-of-vatiquinone-for-the-treatment-of-mitochondrial-disease-associated-seizures-301867528.html

    PR NEWSWIRE
    29 Jun 2023
    Share Share
    PTC Announces Initiation of Global Ph 3 Trial to Evaluate Vatiquinone
    PTC Announces Initiation of Global Ph 3 Trial to Evaluate Vatiquinone

    30 Nov 2020

    // PRESS RELEASE

    https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-announces-initiation-global-phase-3-clinical

    PRESS RELEASE
    30 Nov 2020
    Share Share
    PTC Announces Initiation of Global Ph3 Trial to Evaluate Vatiquinone
    PTC Announces Initiation of Global Ph3 Trial to Evaluate Vatiquinone

    30 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-initiation-of-global-phase-3-clinical-trial-to-evaluate-vatiquinone-in-friedreich-ataxia-301181396.html

    PRNEWSWIRE
    30 Nov 2020
    Share Share